4 Biomedical Stocks Canaccord Loves

Loading...
Loading...

Cannacord recently attended the EuroPCR 2015 scientific sessions in Paris, and analysts followed up on the event by releasing a report this week on four of their top biotech stock picks. According to the report, the event provided updates that were “testament to our belief that the interventional cardiology arena will be one of the most dynamic in med-tech for years to come.”

Here’s a quick takeaway summary of what Cannacord saw at the conference.

TMVR takes center stage
Analysts note that the sessions discussing transcatheter mitral valves (TMVR) were especially crowded. The unproven devices are still very early in their development, and many questions remain unanswered at this point. However, analysts explain that the need to find a less-invasive treatment for mitral regurgitation is “inarguable,” and some form of TMVR could eventually prove to be a viable solution.

TAVI still showing potential
Despite the excitement surrounding TMVR, transcatheter aortic valve implantation (TAVI) still shows lots of promise. Both Edwards Lifesciences Corp EW and Medtronic PLC MDT have reported continuing success with SAPIEN 3 and Evolut R, respectively. Analysts do note growing concerns over seemingly manageable thrombus formation on some valves. Analysts will be watching for important TAVI clinical data on the calendar in 2016 and predict “strong growth” in TAVI through 2020.

Stock picks
Cannacord included four Buy-rated biotech stock picks in the report:

  • Edwards Lifesciences (price target- $160)
  • Avinger Inc AVGR (price target- $18)
  • Neovasc Inc NVCN (price target- $15)
  • The Spectanetics Corp SPNC (price target- $36)
Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorBiotechLong IdeasPrice TargetAnalyst RatingsTrading IdeasGeneral
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...